VIGENE CAPITAL
Vigene Capital is an independent investment banking firm serving worldwide companies that participate in the China market. It concentrates our energy on corporate financing, M&A, restructuring, strategic advisory services for technology companies, fast-growing enterprises, and other vital companies with core competence or distinctive business models across industry sectors.
VIGENE CAPITAL
Founded:
2012-01-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving
Similar Organizations
EXS Capital
EXS Capital is an independent investment firm.
Overture Advisors
Overture Advisors is an independent investment banking service provider company.
RB Capital Partners
RB Capital Partners is an independent investment consulting firm focusing on companies.
More informations about "Vigene Capital"
Edward Shu - LinkedIn
Edward Shu is a seasoned professional currently serving as the Managing Director at Vigene Capital. With a strong background in finance and investment, Edward Shu excels in …See details»
Vigene Is Acquired By Charles River - Baird
Vigene Biosciences, Inc. (“Vigene” or the “Company”), a portfolio company of Signet Healthcare Partners (“Signet”), has signed a definitive agreement to be acquired by Charles River Laboratories International, Inc. (“Charles River”) …See details»
Vigene Capital - Crunchbase
Companies like Vigene Capital include EXS Capital, RB Capital Partners, and Overture Advisors. RB Capital Partners London , England , United Kingdom 1-10 employeesSee details»
Vigene Biosciences Is Now Part of Charles River
In June 2021, Charles River acquired Vigene Biosciences, a trusted leader in contract development and manufacturing (CDMO) solutions for cell and gene therapy. ... efficient production timelines through our integrated global network …See details»
Vigene Biosciences Secures Institutional Investment in New Round …
Apr 29, 2019 The growth capital will be used to support Vigene's expansion into a new facility to support the growing demand for viral vector and plasmid production in the rapidly expanding …See details»
Charles River Laboratories Completes Acquisition of Vigene …
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Charles River Laboratories Completes Acquisition of Rockville’s …
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Vigene Capital - Tech Stack, Apps, Patents & Trademarks
Vigene Capital is an independent investment banking firm serving worldwide companies.See details»
Vigene Biosciences Acquired by Charles River …
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based gene delivery solutions. Vigene’s primary area of …See details»
Vigene Biosciences Secures Institutional Investment in New Round …
Apr 29, 2019 Vigene Biosciences Jeffrey Hung, Ph.D. Chief Commercial Officer Vigene Biosciences 301-251-6638 [email protected] Signet Healthcare Partners Jerry Liao 212-893 …See details»
Charles River Signals Gene Therapy Expansion with Vigene …
May 18, 2021 The Vigene purchase continues a series of acquisitions for Charles River in recent years that has seen it buy Cognate, contract research organization (CRO) Retrogenix for $48 …See details»
Vigene Biosciences 2025 Company Profile: Valuation, Investors ...
BroadOak Capital Partners, Current Yield with Participation Fund, and Signet Healthcare Partners have invested in Vigene Biosciences. Who are Vigene Biosciences’s competitors? iVexSol , …See details»
Charles River Laboratories Completes Acquisition of Vigene
Jun 29, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Charles River To Acquire Vigene Biosciences For $292.5 Mln In
May 17, 2021 The addition of Vigene Biosciences' extensive gene therapy expertise will enable Charles River to expand its comprehensive cell and gene therapy portfolio to span each of the …See details»
Charles River ups CDMO offering in Vigene buy - BioProcess Insider
May 18, 2021 Charles River Labs plans to buy gene-therapy focused CDMO Vigene Biosciences for $300 million, further expanding its presence in the manufacturing space. The deal – which …See details»
Charles River (CRL) Advances in Gene Therapy With Vigene Buyout
Jun 30, 2021 Vigene is expected to generate annual revenuesof $30 to $35 million in 2021 and is expected to grow at least 25% annually over the next five years. Share Price Performance …See details»
Charles River (CRL) Advances in Gene Therapy With Vigene Buyout
Jun 30, 2021 Vigene is expected to generate annual revenuesof $30 to $35 million in 2021 and is expected to grow at least 25% annually over the next five years. Share Price Performance …See details»
Charles River Snags Gene Therapy CDMO Vigene Biosciences
Jul 2, 2021 Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and manufacturing organization (CDMO), providing viral vector-based …See details»
Vigene Biosciences Receives Growth Capital Financing
Apr 29, 2019 The growth capital will be used to support Vigene’s expansion into a new facility to support the demand for viral vector and plasmid production in the fields of cell and gene …See details»
Trump Organization Sues Capital One for Closing Its Accounts
Mar 7, 2025 President Trump’s family business sued Capital One on Friday for “unjustifiably terminating” more than 300 of its bank accounts after the Jan. 6, 2021, attack on the Capitol, …See details»